Recurrent high grade B-cell lymphoma with MYC and BCL2 rearrangements

Clinical trials for Recurrent high grade B-cell lymphoma with MYC and BCL2 rearrangements explained in plain language.

Never miss a new study

Get alerted when new Recurrent high grade B-cell lymphoma with MYC and BCL2 rearrangements trials appear

Sign up with your email to follow new studies for Recurrent high grade B-cell lymphoma with MYC and BCL2 rearrangements, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet recruiting 1

Can a Two-Pronged antibody boost chemo against tough lymphomas?

Disease control Not yet recruiting

This trial tests whether adding the bispecific antibody glofitamab to standard chemoimmunotherapy can improve outcomes for people with Burkitt lymphoma or high-grade B-cell lymphoma with MYC and BCL2 rearrangements. These are fast-growing cancers that can be hard to treat. The st…

Matched conditions: RECURRENT HIGH GRADE B-CELL LYMPHOMA WITH MYC AND BCL2 REARRANGEMENTS

Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Aug 21, 2026 00:00 UTC

Recurrent high grade B-cell lymphoma with MYC and BCL2 rearrangements

Get alerted when new Recurrent high grade B-cell lymphoma with MYC and BCL2 rearrangements trials appear

Can a Two-Pronged antibody boost chemo against tough lymphomas?